Phase I trial of nedaplatin and S-1 in patients with advanced squamous cell lung cancer

The platinum doublet is considered to be the standard cytotoxic chemotherapy for advanced lung cancer. It has been previously reported that nedaplatin and S-1 have clinical efficacy against squamous cell lung cancer. As the combination of nedaplatin and S-1 has never been studied for advanced squamo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaji, Nobuhiro, Ishii, Tomoya, Ueda, Yutaka, Ichikawa, Hirohisa, Kishimoto, Nobuhito, Kadowaki, Norimitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657081/
https://www.ncbi.nlm.nih.gov/pubmed/33194196
http://dx.doi.org/10.3892/mco.2020.2159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657081/
https://www.ncbi.nlm.nih.gov/pubmed/33194196
http://dx.doi.org/10.3892/mco.2020.2159

Ejemplares similares